0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-39Q12852
Home | Market Reports | Health| Health Conditions| Cancer
Global Oncolytic Virus Therapy Sales Market Report 2023
BUY CHAPTERS

Oncolytic Virus Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-39Q12852
Report
March 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncolytic Virus Therapy - Market Size

The global market for Oncolytic Virus Therapy was estimated to be worth US$ 6 million in 2023 and is forecast to a readjusted size of US$ 29 million by 2030 with a CAGR of 24.9% during the forecast period 2024-2030

Oncolytic Virus Therapy - Market

Oncolytic Virus Therapy - Market

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Oncolytic Virus Therapy by region & country, by Type, and by Application.
The Oncolytic Virus Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Therapy.
Market Segmentation

Scope of Oncolytic Virus Therapy - Market Report

Report Metric Details
Report Name Oncolytic Virus Therapy - Market
Forecasted market size in 2030 US$ 29 million
CAGR 24.9%
Forecasted years 2024 - 2030
Segment by Type:
  • HSV-based Oncolytic Viruses
  • Adenoviruses-based Oncolytic Viruses
  • Vaccinia Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses
Segment by Application
  • Melanoma
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Oncolytic Virus Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Oncolytic Virus Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Oncolytic Virus Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Oncolytic Virus Therapy - Market size in 2030?

Ans: The Oncolytic Virus Therapy - Market size in 2030 will be US$ 29 million.

Who are the main players in the Oncolytic Virus Therapy - Market report?

Ans: The main players in the Oncolytic Virus Therapy - Market are Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics, Cold Genesys

What are the Application segmentation covered in the Oncolytic Virus Therapy - Market report?

Ans: The Applications covered in the Oncolytic Virus Therapy - Market report are Melanoma, Prostate Cancer, Breast Cancer, Ovarian Cancer, Others

What are the Type segmentation covered in the Oncolytic Virus Therapy - Market report?

Ans: The Types covered in the Oncolytic Virus Therapy - Market report are HSV-based Oncolytic Viruses, Adenoviruses-based Oncolytic Viruses, Vaccinia Virus-based Oncolytic Viruses, Vesicular Stomatitis Virus-based Oncolytic Viruses, Newcastle Disease Virus-based Oncolytic Viruses

1 Market Overview
1.1 Oncolytic Virus Therapy Product Introduction
1.2 Global Oncolytic Virus Therapy Market Size Forecast
1.3 Oncolytic Virus Therapy Market Trends & Drivers
1.3.1 Oncolytic Virus Therapy Industry Trends
1.3.2 Oncolytic Virus Therapy Market Drivers & Opportunity
1.3.3 Oncolytic Virus Therapy Market Challenges
1.3.4 Oncolytic Virus Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Oncolytic Virus Therapy Players Revenue Ranking (2023)
2.2 Global Oncolytic Virus Therapy Revenue by Company (2019-2024)
2.3 Key Companies Oncolytic Virus Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Oncolytic Virus Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Oncolytic Virus Therapy
2.6 Oncolytic Virus Therapy Market Competitive Analysis
2.6.1 Oncolytic Virus Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Oncolytic Virus Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 HSV-based Oncolytic Viruses
3.1.2 Adenoviruses-based Oncolytic Viruses
3.1.3 Vaccinia Virus-based Oncolytic Viruses
3.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
3.1.5 Newcastle Disease Virus-based Oncolytic Viruses
3.2 Global Oncolytic Virus Therapy Sales Value by Type
3.2.1 Global Oncolytic Virus Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Oncolytic Virus Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Oncolytic Virus Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Melanoma
4.1.2 Prostate Cancer
4.1.3 Breast Cancer
4.1.4 Ovarian Cancer
4.1.5 Others
4.2 Global Oncolytic Virus Therapy Sales Value by Application
4.2.1 Global Oncolytic Virus Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Oncolytic Virus Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Oncolytic Virus Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Oncolytic Virus Therapy Sales Value by Region
5.1.1 Global Oncolytic Virus Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Oncolytic Virus Therapy Sales Value by Region (2019-2024)
5.1.3 Global Oncolytic Virus Therapy Sales Value by Region (2025-2030)
5.1.4 Global Oncolytic Virus Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Oncolytic Virus Therapy Sales Value, 2019-2030
5.2.2 North America Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Oncolytic Virus Therapy Sales Value, 2019-2030
5.3.2 Europe Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Oncolytic Virus Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Oncolytic Virus Therapy Sales Value, 2019-2030
5.5.2 South America Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Oncolytic Virus Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Oncolytic Virus Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Oncolytic Virus Therapy Sales Value
6.3 United States
6.3.1 United States Oncolytic Virus Therapy Sales Value, 2019-2030
6.3.2 United States Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Oncolytic Virus Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Oncolytic Virus Therapy Sales Value, 2019-2030
6.4.2 Europe Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Oncolytic Virus Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Oncolytic Virus Therapy Sales Value, 2019-2030
6.5.2 China Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Oncolytic Virus Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Oncolytic Virus Therapy Sales Value, 2019-2030
6.6.2 Japan Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Oncolytic Virus Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Oncolytic Virus Therapy Sales Value, 2019-2030
6.7.2 South Korea Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Oncolytic Virus Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Oncolytic Virus Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Oncolytic Virus Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Oncolytic Virus Therapy Sales Value, 2019-2030
6.9.2 India Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Oncolytic Virus Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Profile
7.1.2 Amgen Main Business
7.1.3 Amgen Oncolytic Virus Therapy Products, Services and Solutions
7.1.4 Amgen Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Amgen Recent Developments
7.2 Oncolytics Biotech
7.2.1 Oncolytics Biotech Profile
7.2.2 Oncolytics Biotech Main Business
7.2.3 Oncolytics Biotech Oncolytic Virus Therapy Products, Services and Solutions
7.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Oncolytics Biotech Recent Developments
7.3 Viralytics
7.3.1 Viralytics Profile
7.3.2 Viralytics Main Business
7.3.3 Viralytics Oncolytic Virus Therapy Products, Services and Solutions
7.3.4 Viralytics Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Transgene SA Recent Developments
7.4 Transgene SA
7.4.1 Transgene SA Profile
7.4.2 Transgene SA Main Business
7.4.3 Transgene SA Oncolytic Virus Therapy Products, Services and Solutions
7.4.4 Transgene SA Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Transgene SA Recent Developments
7.5 Oncolys BioPharma
7.5.1 Oncolys BioPharma Profile
7.5.2 Oncolys BioPharma Main Business
7.5.3 Oncolys BioPharma Oncolytic Virus Therapy Products, Services and Solutions
7.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Oncolys BioPharma Recent Developments
7.6 Targovax
7.6.1 Targovax Profile
7.6.2 Targovax Main Business
7.6.3 Targovax Oncolytic Virus Therapy Products, Services and Solutions
7.6.4 Targovax Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Targovax Recent Developments
7.7 PsiOxus Therapeutics
7.7.1 PsiOxus Therapeutics Profile
7.7.2 PsiOxus Therapeutics Main Business
7.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
7.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 PsiOxus Therapeutics Recent Developments
7.8 SillaJen Biotherapeutics
7.8.1 SillaJen Biotherapeutics Profile
7.8.2 SillaJen Biotherapeutics Main Business
7.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
7.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 SillaJen Biotherapeutics Recent Developments
7.9 Sorrento Therapeutics
7.9.1 Sorrento Therapeutics Profile
7.9.2 Sorrento Therapeutics Main Business
7.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
7.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 Sorrento Therapeutics Recent Developments
7.10 Lokon Pharma
7.10.1 Lokon Pharma Profile
7.10.2 Lokon Pharma Main Business
7.10.3 Lokon Pharma Oncolytic Virus Therapy Products, Services and Solutions
7.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Lokon Pharma Recent Developments
7.11 Genelux Corporation
7.11.1 Genelux Corporation Profile
7.11.2 Genelux Corporation Main Business
7.11.3 Genelux Corporation Oncolytic Virus Therapy Products, Services and Solutions
7.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 Genelux Corporation Recent Developments
7.12 Vyriad
7.12.1 Vyriad Profile
7.12.2 Vyriad Main Business
7.12.3 Vyriad Oncolytic Virus Therapy Products, Services and Solutions
7.12.4 Vyriad Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 Vyriad Recent Developments
7.13 TILT Biotherapeutics
7.13.1 TILT Biotherapeutics Profile
7.13.2 TILT Biotherapeutics Main Business
7.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
7.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.13.5 TILT Biotherapeutics Recent Developments
7.14 Cold Genesys
7.14.1 Cold Genesys Profile
7.14.2 Cold Genesys Main Business
7.14.3 Cold Genesys Oncolytic Virus Therapy Products, Services and Solutions
7.14.4 Cold Genesys Oncolytic Virus Therapy Revenue (US$ Million) & (2019-2024)
7.14.5 Cold Genesys Recent Developments
8 Industry Chain Analysis
8.1 Oncolytic Virus Therapy Industrial Chain
8.2 Oncolytic Virus Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Oncolytic Virus Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Oncolytic Virus Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Oncolytic Virus Therapy Market Trends
    Table 2. Oncolytic Virus Therapy Market Drivers & Opportunity
    Table 3. Oncolytic Virus Therapy Market Challenges
    Table 4. Oncolytic Virus Therapy Market Restraints
    Table 5. Global Oncolytic Virus Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Oncolytic Virus Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Oncolytic Virus Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Oncolytic Virus Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Oncolytic Virus Therapy
    Table 10. Global Oncolytic Virus Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Oncolytic Virus Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Oncolytic Virus Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Oncolytic Virus Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Oncolytic Virus Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Oncolytic Virus Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Oncolytic Virus Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Oncolytic Virus Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Oncolytic Virus Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Oncolytic Virus Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Oncolytic Virus Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Oncolytic Virus Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Oncolytic Virus Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Oncolytic Virus Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Oncolytic Virus Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Oncolytic Virus Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Oncolytic Virus Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Oncolytic Virus Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Oncolytic Virus Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Amgen Basic Information List
    Table 32. Amgen Description and Business Overview
    Table 33. Amgen Oncolytic Virus Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Amgen (2019-2024)
    Table 35. Amgen Recent Developments
    Table 36. Oncolytics Biotech Basic Information List
    Table 37. Oncolytics Biotech Description and Business Overview
    Table 38. Oncolytics Biotech Oncolytic Virus Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Oncolytics Biotech (2019-2024)
    Table 40. Oncolytics Biotech Recent Developments
    Table 41. Viralytics Basic Information List
    Table 42. Viralytics Description and Business Overview
    Table 43. Viralytics Oncolytic Virus Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Viralytics (2019-2024)
    Table 45. Viralytics Recent Developments
    Table 46. Transgene SA Basic Information List
    Table 47. Transgene SA Description and Business Overview
    Table 48. Transgene SA Oncolytic Virus Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Transgene SA (2019-2024)
    Table 50. Transgene SA Recent Developments
    Table 51. Oncolys BioPharma Basic Information List
    Table 52. Oncolys BioPharma Description and Business Overview
    Table 53. Oncolys BioPharma Oncolytic Virus Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Oncolys BioPharma (2019-2024)
    Table 55. Oncolys BioPharma Recent Developments
    Table 56. Targovax Basic Information List
    Table 57. Targovax Description and Business Overview
    Table 58. Targovax Oncolytic Virus Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Targovax (2019-2024)
    Table 60. Targovax Recent Developments
    Table 61. PsiOxus Therapeutics Basic Information List
    Table 62. PsiOxus Therapeutics Description and Business Overview
    Table 63. PsiOxus Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Oncolytic Virus Therapy Business of PsiOxus Therapeutics (2019-2024)
    Table 65. PsiOxus Therapeutics Recent Developments
    Table 66. SillaJen Biotherapeutics Basic Information List
    Table 67. SillaJen Biotherapeutics Description and Business Overview
    Table 68. SillaJen Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Oncolytic Virus Therapy Business of SillaJen Biotherapeutics (2019-2024)
    Table 70. SillaJen Biotherapeutics Recent Developments
    Table 71. Sorrento Therapeutics Basic Information List
    Table 72. Sorrento Therapeutics Description and Business Overview
    Table 73. Sorrento Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Sorrento Therapeutics (2019-2024)
    Table 75. Sorrento Therapeutics Recent Developments
    Table 76. Lokon Pharma Basic Information List
    Table 77. Lokon Pharma Description and Business Overview
    Table 78. Lokon Pharma Oncolytic Virus Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Lokon Pharma (2019-2024)
    Table 80. Lokon Pharma Recent Developments
    Table 81. Genelux Corporation Basic Information List
    Table 82. Genelux Corporation Description and Business Overview
    Table 83. Genelux Corporation Oncolytic Virus Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Genelux Corporation (2019-2024)
    Table 85. Genelux Corporation Recent Developments
    Table 86. Vyriad Basic Information List
    Table 87. Vyriad Description and Business Overview
    Table 88. Vyriad Oncolytic Virus Therapy Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Vyriad (2019-2024)
    Table 90. Vyriad Recent Developments
    Table 91. TILT Biotherapeutics Basic Information List
    Table 92. TILT Biotherapeutics Description and Business Overview
    Table 93. TILT Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Oncolytic Virus Therapy Business of TILT Biotherapeutics (2019-2024)
    Table 95. TILT Biotherapeutics Recent Developments
    Table 96. Cold Genesys Basic Information List
    Table 97. Cold Genesys Description and Business Overview
    Table 98. Cold Genesys Oncolytic Virus Therapy Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Oncolytic Virus Therapy Business of Cold Genesys (2019-2024)
    Table 100. Cold Genesys Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Oncolytic Virus Therapy Downstream Customers
    Table 104. Oncolytic Virus Therapy Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Oncolytic Virus Therapy Product Picture
    Figure 2. Global Oncolytic Virus Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Oncolytic Virus Therapy Report Years Considered
    Figure 5. Global Oncolytic Virus Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncolytic Virus Therapy Revenue in 2023
    Figure 7. Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. HSV-based Oncolytic Viruses Picture
    Figure 9. Adenoviruses-based Oncolytic Viruses Picture
    Figure 10. Vaccinia Virus-based Oncolytic Viruses Picture
    Figure 11. Vesicular Stomatitis Virus-based Oncolytic Viruses Picture
    Figure 12. Newcastle Disease Virus-based Oncolytic Viruses Picture
    Figure 13. Global Oncolytic Virus Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Oncolytic Virus Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Product Picture of Melanoma
    Figure 16. Product Picture of Prostate Cancer
    Figure 17. Product Picture of Breast Cancer
    Figure 18. Product Picture of Ovarian Cancer
    Figure 19. Product Picture of Others
    Figure 20. Global Oncolytic Virus Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Oncolytic Virus Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 22. North America Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 23. North America Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 24. Europe Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 25. Europe Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 26. Asia Pacific Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 27. Asia Pacific Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 28. South America Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 29. South America Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 30. Middle East & Africa Oncolytic Virus Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 31. Middle East & Africa Oncolytic Virus Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 32. Key Countries/Regions Oncolytic Virus Therapy Sales Value (%), (2019-2030)
    Figure 33. United States Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 34. United States Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 35. United States Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 36. Europe Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 37. Europe Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 38. Europe Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 39. China Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 40. China Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 41. China Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 42. Japan Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Japan Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 44. Japan Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 45. South Korea Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 46. South Korea Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 47. South Korea Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 48. Southeast Asia Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 50. Southeast Asia Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 51. India Oncolytic Virus Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 52. India Oncolytic Virus Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 53. India Oncolytic Virus Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 54. Oncolytic Virus Therapy Industrial Chain
    Figure 55. Oncolytic Virus Therapy Manufacturing Cost Structure
    Figure 56. Channels of Distribution (Direct Sales, and Distribution)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS